Our work with NSCLC-PDEs confirmed a significant relationship with PDE responses to chemotherapy drugs and patient outcomes, and the clinical predictivity of the platform has also been confirmed through similar work by others for colorectal cancer (CRC)22. Here, ALDH7A1 is linked to non-small cell lung carcinoma.